TG Therapeutics Inc (STU:NKB2)
€ 16.226 -0.264 (-1.6%) Market Cap: 2.53 Bil Enterprise Value: 2.44 Bil PE Ratio: 80.55 PB Ratio: 17.10 GF Score: 72/100

TG Therapeutics Inc (STU:NKB2) Transcripts

  • 1